Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

Eitemau Tebyg

• Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally
  gan: Navab, Mohamad, et al.
  Cyhoeddwyd: (2011)
• A novel approach to oral apoA-I mimetic therapy
  gan: Chattopadhyay, Arnab, et al.
  Cyhoeddwyd: (2013)
• Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
  gan: Su, Feng, et al.
  Cyhoeddwyd: (2010)
• Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice
  gan: Vaziri, Nosratola D., et al.
  Cyhoeddwyd: (2010)
• Apolipoprotein A-I Mimetics
  gan: Reddy, Srinivasa T., et al.
  Cyhoeddwyd: (2014)